Mega CapHealthcareDividend

MCK — McKesson Corporation

Healthcare Distributors · Founded 1833 · Irving, Texas · CEO: Brian Tyler

McKesson is one of the three dominant U.S. pharmaceutical distributors alongside AmerisourceBergen (Cencora) and Cardinal Health, distributing branded and generic drugs, medical supplies, and specialty pharmaceuticals to pharmacies, hospitals, and clinics. As a distributor, McKesson's margins are thin but volumes are enormous. The company also operates oncology specialty distribution and has a growing presence in oncology practice management through The US Oncology Network.

How McKesson Corporation Makes Money

Pharmaceutical distribution of branded and generic drugs to retail pharmacies, hospitals, and health systems

Medical-Surgical distribution of supplies and equipment to physician offices and home health providers

Oncology specialty distribution and practice management through US Oncology Network

International pharmaceutical distribution operations (primarily Canada and Europe)

Key Metrics Investors Watch

Pharmaceutical distribution revenue growth and market share
Adjusted operating profit (distribution margins are thin, so operating leverage matters)
GLP-1 drug volume contribution (Ozempic/Wegovy distribution)
Oncology segment revenue and practice count growth
Return of capital (buybacks and dividends)

Competitive Advantages

Scale and logistics network make distribution switching extremely costly for large pharmacy chains
Three-distributor oligopoly limits competitive pressure on distribution fees
US Oncology Network is a leading oncology practice affiliation model with hundreds of oncologists
Specialty distribution for complex biologics and oncology drugs is a high-growth, higher-margin segment

Key Risks

Thin distribution margins mean any revenue shortfall or pricing compression has outsized earnings impact
Drug pricing transparency legislation could pressure distribution spreads
Opioid settlement obligations (resolved but legacy liability management ongoing)
Customer concentration — large pharmacy chains (CVS, Walgreens) have significant negotiating leverage

Dividend & Capital Return

McKesson pays a quarterly dividend and is an aggressive share repurchaser, returning most of its free cash flow to shareholders given limited organic reinvestment needs.

I Document Every Trade — Even the Losses

Options record: 1W-8L. Net worth: 100% GSE preferred. Get the unfiltered updates.

Unsubscribe anytime. I respect your inbox more than Congress respects property rights.

Frequently Asked Questions

What does McKesson actually do?

McKesson distributes pharmaceutical drugs and medical products from manufacturers to pharmacies, hospitals, and healthcare providers across the United States and internationally. It acts as the logistics layer of the drug supply chain, moving products efficiently at enormous scale. This is educational content, not financial advice.

Why are pharmaceutical distributor margins so thin?

Drug distributors like McKesson compete intensely for large pharmacy chain contracts, compressing distribution fees. Most of McKesson's revenue passes through as cost of goods, leaving operating margins in the low single digits, though the absolute dollar profits are substantial given hundreds of billions in revenue. This is educational content, not financial advice.

Does McKesson pay a dividend?

Yes, McKesson pays a quarterly dividend and prioritizes share buybacks as its primary capital return mechanism. The combination of dividends and buybacks returns most of free cash flow to shareholders annually. This is educational content, not financial advice.

What is the US Oncology Network?

US Oncology Network is McKesson's affiliated network of independent oncology practices providing business services, technology, and specialty drug distribution to community-based oncologists. It is one of the largest oncology networks in the U.S. by physician count. This is educational content, not financial advice.

How does McKesson benefit from GLP-1 drugs?

McKesson distributes GLP-1 drugs like Ozempic and Wegovy to pharmacies and healthcare providers, benefiting from the massive volume growth in these drugs. While margins per unit are thin, the volume contribution from the GLP-1 category has been significant for McKesson's top-line growth. This is educational content, not financial advice.

Related Stocks

UNH

UnitedHealth Group Incorporated

Healthcare

UnitedHealth Group is the largest health insurance company in the US, serving tens of millions of members through UnitedHealthcare. The company also operates Optum, a diversified health services platform spanning pharmacy benefits, care delivery, and health technology.

CVS

CVS Health Corporation

Healthcare

CVS Health is a vertically integrated healthcare company operating pharmacy benefit management (Caremark), retail pharmacies (9,000+ stores), health insurance (Aetna), and clinic-based care (MinuteClinic, Oak Street Health). The 2018 acquisition of Aetna for $69 billion transformed CVS from a pharmacy chain into a healthcare ecosystem player. CVS manages prescription drug benefits for tens of millions of Americans through Caremark and continues to expand primary care through Oak Street Health, acquired in 2023.

CI

The Cigna Group

Healthcare

The Cigna Group is a global healthcare services and insurance company serving employers, government programs, and individuals. Cigna operates two primary segments: Evernorth Health Services (pharmacy benefits management via Express Scripts, specialty pharmacy, and care solutions) and Cigna Healthcare (commercial health insurance). Express Scripts is one of the three dominant PBMs in the U.S., processing hundreds of millions of prescriptions annually. Cigna divested its Medicare Advantage, Medicare Supplement, and Part D businesses to HCSC in 2024.

ABC

Cencora, Inc.

Healthcare

Cencora (formerly AmerisourceBergen, rebranded in 2023) is one of the three dominant U.S. pharmaceutical distributors, ranking alongside McKesson and Cardinal Health. The company distributes specialty and traditional pharmaceuticals to community pharmacies, health systems, and physician offices. Cencora has a particularly strong position in specialty drug distribution through its AmerisourceBergen Drug Corporation and World Courier specialty logistics operations. Strategic partnerships with Walgreens Boots Alliance give Cencora significant volume and distribution advantage.

CAH

Cardinal Health, Inc.

Healthcare

Cardinal Health is one of the three dominant U.S. pharmaceutical distributors and a major medical products company. Its pharmaceutical distribution segment provides drug logistics to health systems, retail pharmacies, and mail-order pharmacies. Its GMPD (Global Medical Products and Distribution) segment manufactures and distributes surgical supplies, exam gloves, and medical-surgical products. Cardinal Health spun off its specialty pharmaceutical distributor Specialty Networks and has been restructuring its medical products business to improve profitability.

Recommended Resources

Tools & books I actually use and recommend

SeekingAlpha Premium

Quant ratings, earnings transcripts, and the stock analysis community where I published 300+ articles.

Try SeekingAlpha

The Intelligent Investor

Ben Graham's timeless guide to value investing. The book Warren Buffett calls "the best investing book ever written."

View on Amazon

Interactive Brokers

Low commissions, global market access, and professional-grade tools. This is where I hold my positions.

Open an Account

Some links above are affiliate links. I only recommend products I personally use. See my full disclosures.

Keep Exploring

Hub

All Stocks

Browse all 134 stock profiles by sector.

Best Stocks For Beginners

Curated stock picks for new investors by goal.

Financial Glossary

Understand the terms investors use every day.

Stock vs ETF

Individual stocks vs ETFs — which is right for you?

ETF Profiles

Deep dives on 90+ ETFs across every category.

Buying Your First Stock

How to open a brokerage and buy your first share.

Browse All 134 Stock Profiles

Company information is based on publicly available disclosures and widely-known business facts. No specific price, earnings, or real-time market data is included. This is educational content — not investment advice.